Home
About
Overview
Sharing Data
ORCID
Help
History (59)
Outcome of a randomized, double-blind, placebo controlled trial of botulinum A toxin for refractory overactive bladder.
Axonal transport of N-terminal huntingtin suggests early pathology of corticostriatal projections in Huntington disease.
Sexual Maturation
Factors influencing pacemaker generator longevity: results from the complete automatic pacing threshold utilization recorded in the CAPTURE Trial.
Fibroblast growth factor 4 gene therapy for chronic ischemic heart disease.
See All 59 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Fibroblast growth factor 4 gene therapy for chronic ischemic heart disease.
Kapur NK, Rade JJ. Fibroblast growth factor 4 gene therapy for chronic ischemic heart disease. Trends Cardiovasc Med. 2008 May; 18(4):133-41.
View in:
PubMed
subject areas
Adenoviridae
Animals
Chronic Disease
Clinical Trials as Topic
Collateral Circulation
Coronary Circulation
Fibroblast Growth Factor 4
Gene Transfer Techniques
Genetic Therapy
Genetic Vectors
Humans
Myocardial Ischemia
Neovascularization, Physiologic
Patient Selection
Time Factors
Treatment Outcome
authors with profiles
Jeffrey J Rade MD